4.6 Article

High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life

Pierantonio Menna et al.

Summary: The study found that posaconazole significantly increases plasma levels of midostaurin in patients, leading to decreased exposure to its metabolites. Hematologists may replace posaconazole with antifungals like micafungin or isavuconazole in response to the risk perception of CYP3A4 inhibition, which may affect midostaurin pharmacokinetics in a different manner. Further large studies are needed to evaluate the risk-benefit ratio of this decision.

CHEMOTHERAPY (2021)

Article Oncology

Invasive Mold Infections in FLT3-Mutated Acute Myeloid Leukemia

Pakpoom Phoompoung et al.

Summary: This study found that the incidence and risk factors for invasive mold infections (IMI) in acute myeloid leukemia (AML) patients carrying FLT3 mutations have not been addressed. Age and FLT3 ITD mutation were identified as independent factors associated with IMI. Additionally, neither midostaurin nor salvage gilteritinib significantly increased the risk of IMI in this population.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)

Review Infectious Diseases

Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?

Giulia Dragonetti et al.

MEDICAL MYCOLOGY (2017)

Article Medicine, General & Internal

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

R. M. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Immunology

Type I interferons in infectious disease

Finlay McNab et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Medicine, General & Internal

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Oliver A. Cornely et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Multidisciplinary Sciences

Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease

KA Whartenby et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)